Latest Production And Operations News

Vertex Minerals has completed construction and begun commissioning of its Gravity Gold plant at the Reward Gold Mine, supported by significant capital raises and strategic hires.

Origin Energy's December 2024 Quarterly Report reveals a 3% revenue increase in its Integrated Gas segment despite a slight production dip, while Octopus Energy continues rapid customer growth, becoming the UK's largest retailer.

MONEYME reports a 54% surge in loan originations and a $1.4 billion loan book in 2Q25, underpinned by fresh growth capital and a strategic shift to secured lending.

Vintage Energy reported a 105% jump in quarterly sales revenue driven by a 90% increase in production, despite operational challenges at its Odin-2 well and the termination of a merger proposal with Galilee Energy.

PainChek Ltd reports robust growth with 100,000 contracted licences globally and positive FDA clearance progress, alongside a promising launch of its Infant App targeting a vast new market.

Frontier Digital Ventures posts a mixed fourth quarter with overall revenue growth but EBITDA pressures, while advancing a strategic review focused on unlocking shareholder value.

ResMed Inc. posted a robust second quarter for fiscal year 2025, with revenue climbing 10% to $1.3 billion and operating profit soaring 52%, driven by strong demand for sleep and breathing health products and operational efficiencies.

RMA Global Limited has reported its first cash flow positive quarter since listing, alongside a 9% revenue increase driven by strong US and ANZ market performance and the strategic acquisition of Curated Social.

Lark Distilling Co. Ltd reported a 7% increase in net sales revenue for Q2FY25, driven by strong growth in direct-to-consumer, global travel retail, and export channels despite domestic B2B challenges. The company is advancing its brand restage and maintaining solid cash reserves.

Austral Resources Australia Ltd reports steady operational progress and promising resource developments in its December 2024 quarter, while navigating an ongoing recapitalisation and leadership transition.

Bioxyne Limited reports a remarkable 77% revenue increase in Q2 FY2025 alongside positive operating cash flow, setting the stage for international growth with upcoming UK export approvals and a planned European GMP facility.

ECS Botanics reports a striking 339% quarter-on-quarter growth in its B2C sales, offsetting a slight dip in total revenue as it pivots to a hybrid B2B and B2C business model. The company’s record harvest and new product launches position it for a promising turnaround.